dry eye disease symptoms

Can cannabis succeed where other compounds have failedUse of a novel semi-fluorinated alkane drug delivery technology as a vehicle to deliver cannabinoids to the ocular surface reached target tissues without systemic side effects in preclinical studies.
Testing at point of care for improved patient satisfaction, re-treatment ratesAfter spending a few months testing for dry eye and treating the tear film before doing preoperative measurements, the re-treatment rate dropped from 11% to 3%.
The role of lid hygiene in ocular surface disease
The role of lid hygiene in ocular surface diseaseThe ocular surface encompasses not only the cornea, but the all-important supporting conjunctiva that is divided into the bulbar, limbal, palpebral, forneaceal, and marginal zones.
Shire gets FDA nod for Xiidra (lifitegrast) for dry eye
Shire gets FDA nod for Xiidra (lifitegrast) for dry eyeShire plc obtained U.S. Food and Drug Administration (FDA) approval for Xiidra (lifitegrast ophthalmic solution) 5%, a twice-daily eye drop indicated for the treatment of the signs and symptoms of dry eye disease in adult patients.
4 steps to beating blepharitisBlepharitis is an inflammatory condition of the eyelids leading to red, irritated, itchy, and dandruff-like scales that form on the eyelashes.
Tear volume – a neglected issue?Dry eye disease is one of the most common conditions encountered by eye care professionals, yet measurement of tear volume remains difficult. A newly developed tool is reliable and straightforward to use.
How punctal plugs may influence tear osmolarity and aid in dry eye therapiesTear osmolarity decreases with punctal plug insertion and serves as a leading indicator of therapeutic efficacy in dry eye disease.
Study: Dry eye may not worsen over timeDry eye disease (DED) has long been thought to be a progressive condition, but a study published in Ophthalmology found that most of its participants who were diagnosed with DED reported no change or some level of improvement.
How TFOS brought dry eye to the forefront of optometryNowadays, you are unlikely to read a journal or go to a meeting without hearing the importance of dry eye disease in our practices and for our surgical patients. This was not always the case. I want to introduce you to the Tear Film and Ocular Surface Society (TFOS) and the brains behind it: David Sullivan, PhD, and his family— Rose, Ben, and Amy—who dedicate their lives to help us better understand dry eye disease.
Why you’re missing the dry eye right in front of you
Why you’re missing the dry eye right in front of youA common barrier to many practitioners is the concern that their practice does not have the patient foundation to make investment in the services economically profitable. I assure you that OSD management will profit the patient in many ways that includes clearer, more comfortable vision, enhancing their productivity and overall wellbeing.